Evidence map›Paper›PMID 32486031›Full record

ArticleCells2020

The Vasopressin Receptor 2 Mutant R137L Linked to the Nephrogenic Syndrome of Inappropriate Antidiuresis (NSIAD) Signals through an Alternative Pathway that Increases AQP2 Membrane Targeting Independently of S256 Phosphorylation.

Marianna Ranieri, Maria Venneri, Tommaso Pellegrino, Mariangela Centrone, Annarita Di Mise, Susanna Cotecchia, Grazia Tamma, Giovanna Valenti

Open access · goldAbstract read
In one paragraph

Article in Cells, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Marianna RanieriDepartment of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, 70125 Bari, Italy.ORCID 0000-0003-3118-5813
Maria VenneriDepartment of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, 70125 Bari, Italy.
Tommaso PellegrinoDepartment of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, 70125 Bari, Italy.
Mariangela CentroneDepartment of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, 70125 Bari, Italy.
Annarita Di MiseDepartment of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, 70125 Bari, Italy.
Susanna CotecchiaDepartment of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, 70125 Bari, Italy.
Grazia TammaDepartment of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, 70125 Bari, Italy.ORCID 0000-0002-8890-0278
Giovanna ValentiDepartment of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, 70125 Bari, Italy.
University of Bari Aldo Moro · ITIstituto Nazionale Biostrutture e Biosistemi · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

NSIAD is a rare X-linked condition, caused by activating mutations in the

Indexed as

Signal TransductionAnimalsAquaporin 2Cell LineCell MembraneCyclic AMP-Dependent Protein KinasesGenetic Diseases, X-LinkedGTP-Binding Protein alpha Subunits, G12-G13HumansInappropriate ADH SyndromeMiceModels, BiologicalMutant ProteinsMutationOsmosisPhosphorylationAquaporin 2AVPR2 protein, humanCyclic AMP-Dependent Protein KinasesGTP-Binding Protein alpha Subunits, G12-G13Mutant ProteinsPhosphoserineProtein Kinase InhibitorsReceptors, Vasopressinrho-Associated Kinasesrho GTP-Binding ProteinsWaterAQP2NSIADRho kinase (ROCK)V2Rvasopressin

Identifiers

PMID32486031
PMCPMC7349359
OpenAlexW3032661276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.